MedTrace Logo

Indications of Erector Spinae Plane Block in Pediatric Patients

NCT03906019 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 141

Last updated 2019-08-01

No results posted yet for this study

Summary

Patients who were operated by Department of Pediatric Surgery between the 1 September 2017 and 28 February 2019 and who received erector spinae plane blocks as a part of postoperative analgesia management will be scanned.

Conditions

  • Postoperative Pain

Interventions

PROCEDURE

ESP Block

Erector spinae plane block performed with 0,25% bupivacaine (0,5 mL/kg-max 20mL), under general anesthesia before the start of the surgery.

DIAGNOSTIC_TEST

FLACC score

For up to 7 years old patients, Face, Legs, Activity, Cry and Consolability (FLACC) scores during postoperative 24h period.

DIAGNOSTIC_TEST

NRS score

Patients older than 7 years, NRS scores during postoperative 24h period.

Sponsors & Collaborators

  • Kocaeli University

    lead OTHER

Principal Investigators

  • Can Aksu, Assistant Professor · Kocaeli University

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-09
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03906019 on ClinicalTrials.gov